ZHB-202

N/A

Report date: 2025/07/16 15:02:13
NME

Base Information

Drug NameZHB-202
Drug Alias NameZHB202ZHB-202QHRD102QHRD-102ZHB-C001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsLymphoma, Extranodal NK-T-CellLymphoma, T-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangzhou Qianhong Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZonhon Biopharma Institute IncChangzhou Qianhong Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, Extranodal NK-T-CellLymphoma, T-CellPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A